Form 4: Therapeutic Solutions International Director Acquires 10 Million Shares at Discount, Disposes of 177 Million Shares
SEC Form 4 Filing
Director Thomas Ichim reports acquiring 10,000,000 shares of Therapeutic Solutions International at $0.0008 per share and disposing of 177,000,000 shares.
Summary
- On May 30, 2024, Thomas Ichim, a director of Therapeutic Solutions International, Inc. (TSOI), acquired 10,000,000 shares of common stock.
- The acquisition price was $0.0008 per share.
- On the same day, Ichim disposed of 177,000,000 shares.
- Following these transactions, Ichim still beneficially owns shares of the company.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative due to the large disposal of shares by a director, which could raise concerns among investors despite the acquisition of a smaller number of shares at a very low price.
Risks
- The large disposal of 177,000,000 shares by a director could be perceived negatively by the market.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. The market will likely scrutinize the reasons behind the director's actions.
Stakeholder Impact
- Shareholders may react to the director's share disposal, potentially impacting the stock price.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of earliest transaction: Acquisition of 10,000,000 shares and disposal of 177,000,000 shares. |
| 05/31/2024 | Date of signature on the Form 4. |
Keywords
Therapeutic Solutions International, TSOI, Form 4, Insider Trading, Beneficial Ownership, Thomas Ichim, Director, Share Acquisition, Share Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.